3rd Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,780,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 21, 2018 $2,780,000 Replaced
3rd Quarter - Amendment Feb 1, 2019 $2,830,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)

LobbyistCovered position, as disclosed
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —

Contacted: Treasury, Dept of; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; SENATE; White House Office; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

Creates Act Transferable exclusivity

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Food & Drug Administration (FDA); White House Office; Office of the Vice President of the United States; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: White House Office; Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Natl Economic Council (NEC); Office of the Vice President of the United States; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Health Issues HCR

Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; SENATE; Executive Office of the President (EOP); Office of the Vice President of the United States; Food & Drug Administration (FDA); Natl Economic Council (NEC); White House Office

Medicare/Medicaid MMM

Medicare Part D Coverage Gap

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; White House Office; Treasury, Dept of; Office of the Vice President of the United States

Budget/Appropriations BUD

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Economic Council (NEC); Executive Office of the President (EOP); Office of the Vice President of the United States

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.